Artrya Share Price and Company Fundamentals
Last traded: Today at 3:14 AM
Artrya Limited operates as a medical technology company that uses artificial intelligence (AI) to identify patients at risk of coronary artery disease. It offers Salix, a cloud-based software that uses its AI to automate the detection of coronary artery disease from coronary computed tomography angiography. The company was incorporated in 2018 and is based in West Perth, Australia.
|Primary activities||Artrya Limited is a medical technology company developing software which automates the analysis of heart computed tomography (CT) scans to assist in the diagnosis of Coronary Artery Disease.|
|Industry / Sector||Health Information Services / Healthcare|
|Mailing address||1257 Hay Street West Perth WA 6005 Australia|
|Phone / Fax||61 8 6478 7816 /|
|Share registry||COMPUTERSHARE INVESTOR SERVICES PTY LIMITED|
Artrya paid $0.00 dividend and the ex-dividend date was .The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.AYA dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
AYA's forward dividend amount is $ and the forward dividend yield is . A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.
As of Oct 2022, following are the company executives and directors listed on Artrya.
|Mr. John Windsor Barrington A.M., F.A.C.I.D., M.B.A.||Co-founder, CEO, MD & Director|
|Mr. John Konstantopoulos B.E.||Co-Founder, Exec. Director of Product & Director|
|Mr. Mark Wainwright||Chief Financial Officer|
|Dr. Julien Flack||Chief Technology Officer|
|Prof. Girish Dwivedi M.D.||Chief Scientific Officer|
|Ms. Janice Marcon||Chief People & Culture Officer|
|Dr. Jacob Agris M.D., Ph.D.||Chief Medical Officer|
|Mr. Riaz Kingston||Head of Bus. Devel.|
|Mr. Nathan Bartrop||Company Sec.|
|Dr. Jacque J. Sokolov B.A., M.D.||Non-Exec. Director, Chair & Pres of Artrya USA Inc||66|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Artrya is and its enterprise value is .
Companies similar to Artrya (AYA)
- Ansell (ANN)
- Cochlear (COH)
- Fisher & Paykel Healthcare Corporation (FPH)
- Estia Health (EHE)
- Healius (HLS)
- Nanosonics (NAN)
- Pro Medicus (PME)
- Resmed Inc (RMD)
- Ramsay Health Care (RHC)
- Polynovo (PNV)
- Sonic Healthcare (SHL)
Artrya (ASX:AYA) Frequently Asked Questions
1. What is Artrya's Stock Symbol?
Artrya trades on ASX under the ticker symbol "AYA".
2. What is Artrya's stock price today?
One share of AYA stock can currently be purchased for approximately $0.61.
3. How can I contact Artrya?
Artrya's mailing address is 1257 Hay Street West Perth WA 6005 Australia. The company can be reached via phone at 61 8 6478 7816.
4. What is Artrya's official website?
The official website of Artrya is https://www.artrya.com.
5. Which share registry manages Artrya's stock?
Artrya's stock is managed by COMPUTERSHARE INVESTOR SERVICES PTY LIMITED.